---
$id: https://graph.org.ai/products/commodity/51162612
$type: Product
source: UNSPSC
code: "51162612"
title: "Carbetapentane"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbetapentane

**UNSPSC Code**: 51162612
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cyclopentane and antitussive agent with the molecular formula C20H31NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32C726X12W, chemically known as 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid but more generally known as pentoxyverine, which bears US NIH Compound Identifier 2562. European Medicines Agency schedules Pentoxyverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09706MIG. World Health Organization schedules pentoxyverine in its Anatomical Therapeutic Chemical (ATC) Classification. PENTOXYVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2.

